In vitrocytocompatibility of one-dimensional and two-dimensional nanostructure-reinforced biodegradable polymeric nanocomposites
- 4 November 2014
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 103 (7) , 2309-2321
Abstract
This study investigates the in vitro cytocompatibility of one‐dimensional and two‐dimensional (1D and 2D) carbon and inorganic nanomaterial reinforced polymeric nanocomposites fabricated using biodegradable polymer poly (propylene fumarate), crosslinking agent N‐vinyl pyrrolidone (NVP) and following nanomaterials: single and multiwalled carbon nanotubes, single and multiwalled graphene oxide nanoribbons, graphene oxide nanoplatelets, molybdenum disulfide nanoplatelets, or tungsten disulfide nanotubes dispersed between 0.02 and 0.2 wt% concentrations in the polymer. The extraction media of unreacted components, crosslinked nanocomposites and their degradation products were examined for effects on viability and attachment using two cell lines: NIH3T3 fibroblasts and MC3T3 preosteoblasts. The extraction media of unreacted PPF/NVP elicited acute dose‐dependent cytotoxicity attributed to leaching of unreacted components into cell culture media. However, extraction media of crosslinked nanocomposites showed no dose dependent adverse effects. Further, all crosslinked nanocomposites showed high viability (78–100%), high cellular attachment (40–55%), and spreading that was confirmed by confocal and scanning electron microscopy. Degradation products of nanocomposites showed a mild dose‐dependent cytotoxicity possibly due to acidic degradation components of PPF. In general, compared to PPF control, none of the nanocomposites showed significant differences in cellular response to unreacted components, crosslinked nanocomposites and their degradation products. Initial minor cytotoxic response and lower cell attachment numbers were observed only for a few nanocomposite groups; these effects were absent at later time points for all PPF nanocomposites. The favorable cytocompatibility results for all the nanocomposites opens avenues for in vivo safety and efficacy studies for bone tissue engineering applications. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103: 2309–2321, 2015.Keywords
Funding Information
- NIH Office of the Director (1DP2OD007394-01)
This publication has 60 references indexed in Scilit:
- Poly(ε-caprolactone)-Banded Spherulites and Interaction with MC3T3-E1 CellsLangmuir, 2012
- Binding of blood proteins to carbon nanotubes reduces cytotoxicityProceedings of the National Academy of Sciences, 2011
- Structure and catalytic properties of hexagonal molybdenum disulfide nanoplatesCatalysis Science & Technology, 2011
- Synthesis of poly(propylene fumarate)Nature Protocols, 2009
- In vivo bone biocompatibility and degradation of porous fumarate‐based polymer/alumoxane nanocomposites for bone tissue engineeringJournal of Biomedical Materials Research Part A, 2009
- Fabrication and in vitro degradation of porous fumarate‐based polymer/alumoxane nanocomposite scaffolds for bone tissue engineeringJournal of Biomedical Materials Research Part A, 2008
- In vitro cytotoxicity of single‐walled carbon nanotube/biodegradable polymer nanocompositesJournal of Biomedical Materials Research Part A, 2007
- Fabrication of porous ultra-short single-walled carbon nanotube nanocomposite scaffolds for bone tissue engineeringBiomaterials, 2007
- Injectable in situ cross-linkable nanocomposites of biodegradable polymers and carbon nanostructures for bone tissue engineeringJournal of Biomaterials Science, Polymer Edition, 2007
- Synthesis of bulk WS2 nanotube phasesMaterials Research Innovations, 1999